NHS gender clinic waiting lists now stretch beyond two and a half years for an initial appointment, leaving trans people facing a stark choice: pay for private care, navigate DIY hormone routes, or wait while dysphoria worsens. The public system has not collapsed in one moment; it has been eroding for years, and the people it was supposed to serve are paying the price.
What does the NHS gender clinic waiting list actually look like?
When people ask me about NHS waiting times, I find myself struggling to give them a number that feels real, because the numbers have become almost surreal. Two and a half years is the figure that gets quoted most often as a minimum for a first appointment at an NHS Gender Dysphoria Clinic. But in practice, many people I hear from have been waiting considerably longer than that, some approaching or exceeding five years from the point of referral to a first clinical conversation.
That is not a wait for treatment. That is a wait to be seen for the first time. After that first appointment, assessment, further appointments, and then any prescription process follow. The treatment itself, hormones or otherwise, can be years beyond that initial contact.
For an adult in their thirties who has known they are trans since childhood, this is a painful but survivable wait in practical terms, even if it is not in emotional ones. For a young person whose body is changing in ways that cause them profound distress, two and a half years is not a wait; it is a sentence.
Why has the NHS gender care system reached this point?
The demand for gender-affirming care has grown significantly over the past decade, as awareness has increased and the social environment, however imperfectly, has become more accepting. More people feel able to come forward and ask for help. That is not a crisis in itself; it is what happens when stigma reduces. The crisis is that the NHS made almost no corresponding investment in capacity.
For years there was effectively one adult Gender Dysphoria Clinic per region, with all referrals funnelling into a handful of clinics nationally. The Tavistock and Portman NHS Foundation Trust's Gender Identity Development Service was the sole dedicated NHS service for children and young people in England. When the Tavistock's GIDS closed, the regional hubs designed to replace it have been slow to open and slower still to reach anything like the capacity needed.
The Cass Review, which is internationally discredited and whose methodology has been widely challenged by gender clinicians and researchers, was used as justification for restricting access to puberty blockers and narrowing the pathway for young people. Whatever one thinks of the review, its practical effect has been to make access harder at exactly the moment when demand was highest and the system least able to meet it.
What I keep hearing from trans people is that they understand NHS resources are stretched. What they cannot understand is why their care was singled out for restrictions that would be unthinkable in almost any other area of medicine. Delay is not neutral. Withholding care is a decision, and it has consequences.
What does private gender-affirming care cost in practice?
Private care exists and, for those who can afford it, it can move much faster. An initial consultation with a private gender specialist might cost anywhere from £150 to £350 or more, depending on the provider and the clinician. Ongoing medication costs vary considerably by what is prescribed and where it is sourced, but even at the lower end of private prescription costs, the monthly outlay adds up.
For someone on a reasonable income in a city with access to private providers, this is manageable, if expensive and deeply unfair. For someone on a low income, in a rural area, or without the literacy or confidence to navigate a private healthcare system, it is simply out of reach. Trans people are not a uniformly affluent group. Many face discrimination in employment, housing, and services that makes financial stability harder, not easier, to maintain. The cost barrier is not an abstract inconvenience; for many people it is an absolute wall.
Some private providers offer sliding-scale fees or try to keep costs accessible. GenderGP at gendergp.com is the service I founded and the one I point people towards when they are ready to take practical steps, because it was built precisely for people the NHS cannot reach. But even with the best intentions, private care cannot substitute for a functioning public system.
What is DIY HRT and why are people turning to it?
DIY HRT, in this context, means sourcing hormone therapy, oestrogen, testosterone, or anti-androgens, without a clinical prescription, typically via online pharmacies operating in jurisdictions with different regulatory frameworks. People research dosages themselves, often using community-sourced information from online trans forums and harm-reduction resources, and self-administer without regular clinical monitoring.
I want to be careful here, because the people doing this are not reckless. They are resourceful people who have been failed by every system that should have helped them, and who have concluded that the risks of DIY HRT are preferable to the harm of waiting years without treatment. In many cases, they are right to make that calculation. Unmonitored hormones carry real risks, particularly around cardiovascular health, liver function, and bone density. But so does untreated gender dysphoria. The research is clear on the mental health impact of delay. So when someone tells me they have gone the DIY route, I do not judge them. I worry for their safety without clinical oversight, and I wish they did not have to make that choice.
What concerns me most about the growth of DIY HRT is not the people doing it; it is what their numbers tell us about the state of public provision. When a significant number of trans people in a wealthy country with a national health service are sourcing medication without clinical support, the system has failed. Full stop.
What are the actual risks of going without clinical oversight?
The risks depend on what is being taken, in what doses, and for how long. Some of the key areas clinicians monitor in people on hormone therapy include:
- Cardiovascular health, particularly in people on oestrogen, where the risk of blood clots is a real consideration that informs the type of oestrogen prescribed and how it is administered.
- Liver function, which can be affected by certain anti-androgens.
- Bone density, which requires monitoring over time, especially where puberty was altered or delayed.
- Hormone levels, because more is not better, and levels outside the therapeutic range can cause harm in both directions.
- Mental health, because good gender-affirming care involves the whole person, not just the prescription.
None of this means hormone therapy itself is dangerous; it is safe and effective when properly supported, and the Endocrine Society guidelines set out clearly how it should be managed. What makes DIY HRT riskier than clinically supervised care is the absence of monitoring, not the medication itself. If you are on this route and you can access any level of clinical oversight, even a sympathetic GP willing to run periodic bloods, please do. It matters.
What can trans people do right now?
The honest answer is that your options depend heavily on where you are, what you can afford, and what is available in your area. Here is what I know from years of conversations with trans people navigating exactly this.
If you are in the UK and on an NHS waiting list, stay on it, because removing yourself closes a door. In parallel, explore whether your GP will prescribe hormones via the shared care model, where a private specialist recommends a treatment plan and your NHS GP prescribes and monitors. Not all GPs will agree, but some will, and it is worth asking directly rather than assuming the answer is no.
If private care is something you can stretch to, even at the cost of other things, the wait times are dramatically shorter and the care, at its best, is genuinely excellent. If you want to take that step, GenderGP at gendergp.com is where I would point you.
If you are already on a DIY route, please try to get some basic clinical oversight in place, even if it is just regular blood tests via your GP. You do not need to tell them you are self-medicating if you are not comfortable doing so; you can ask for the bloods on other grounds. Your safety matters more than the elegance of the pathway.
And if you are a clinician, a GP, a practice nurse, a pharmacist, or anyone else working in healthcare who reads this: trans people in your area are likely struggling to access care. A little knowledge, a willingness to engage with shared care, and the basic decency of not making someone feel like a problem will go further than you might think.
Is there any prospect of improvement?
The honest picture is mixed. There has been political discussion about expanding capacity and the new regional hubs for young people are, in principle, a structural improvement on a single national service, if they are resourced properly and staffed by people with genuine expertise. In practice, progress has been slow and the ideological climate around trans healthcare has made straightforward investment politically complicated in ways that no other area of medicine faces.
What would actually help is straightforward enough: more funded clinicians, a genuine shared-care pathway that GPs are trained and supported to engage with, the removal of unnecessary gatekeeping steps that exist nowhere else in medicine, and a recognition that delay causes harm. None of that requires a revolution. It requires the will to treat trans people the way we treat everyone else.
Until that happens, trans people in the UK are navigating a system that was not built for them and is not working for them. They deserve better than this, and the fact that so many are finding ways through anyway is a testament to their resilience, not to the system's adequacy.
If there is a topic that you would like me to cover, just let Sammy know.
Dr Helen Webberley is a gender specialist, medical educator, and advocate, and the founder of GenderGP. She writes about trans healthcare, rights, and the lives at the centre of this subject.
Comments